Liveyon PUREŽ Debuts Clinical Trial Grade Stem Cell Concentrate Derived from Umbilical Cord Blood

Friday, March 1, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Liveyon Labs Sets New Industry Standard for Characterization and Consistency in Live Total Nucleated Cell Counts, Viability, Purity and Safety

Liveyon, the global leader in regenerative medicine, is proud to introduce Liveyon PUREŽ, a clinical trial grade stem cell concentrate derived from umbilical cord blood. Following the adage, "If you want something done right do it yourself," Liveyon is for the first time manufacturing this innovative product at Liveyon Labs, the company's own FDA inspected and cGMP certified facility in Yorba Linda, California.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store